US Stock MarketDetailed Quotes

Matinas BioPharma (MTNB)

Watchlist
  • 0.5000
  • -0.0250-4.76%
Close Apr 17 16:00 ET
  • 0.5000
  • 0.00000.00%
Post 20:01 ET
3.20MMarket Cap-0.25P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Matinas BioPharma (MTNB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-65.48%6.96M
-60.38%1.6M
-64.00%1.58M
-68.54%1.84M
-67.03%1.95M
-18.90%20.16M
-31.41%4.04M
-28.58%4.38M
-5.20%5.84M
-11.67%5.9M
Selling and administrative expenses
-21.24%6.88M
-3.73%1.6M
-26.38%1.58M
-25.57%1.84M
-24.23%1.86M
-15.85%8.73M
-25.20%1.66M
-24.55%2.14M
-5.08%2.47M
-9.44%2.46M
-General and administrative expense
-21.24%6.88M
-3.73%1.6M
-26.38%1.58M
-25.57%1.84M
-24.23%1.86M
-15.85%8.73M
-25.20%1.66M
-24.55%2.14M
-5.08%2.47M
-9.44%2.46M
Research and development costs
-99.26%85K
--0
--0
--0
-97.53%85K
-21.09%11.43M
-35.17%2.38M
-32.05%2.24M
-5.28%3.37M
-13.20%3.45M
Operating profit
65.48%-6.96M
60.38%-1.6M
64.00%-1.58M
68.54%-1.84M
67.03%-1.95M
15.16%-20.16M
31.41%-4.04M
28.58%-4.38M
5.20%-5.84M
-5.66%-5.9M
Net non-operating interest income expense
Other net income (expense)
18.81%-3.39M
93.03%-312K
-57.55%45K
-2,940.00%-3.41M
271.79%290K
-605.95%-4.17M
-880.98%-4.48M
34.18%106K
21.21%120K
6.85%78K
Gain on sale of security
---3.16M
--0
----
---3.46M
--294K
----
----
----
----
----
Special income (charges)
100.84%37K
98.35%-73K
--0
--110K
----
-1,015.50%-4.43M
---4.43M
--0
--0
----
-Less:Impairment of capital assets
--0
----
----
----
----
--4.43M
----
----
----
----
-Gain on sale of business
----
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
--37K
---73K
--0
--110K
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
-199.62%-261K
-443.18%-239K
-57.55%45K
-152.50%-63K
-105.13%-4K
-22.94%262K
-149.44%-44K
34.18%106K
21.21%120K
6.85%78K
Income before tax
57.48%-10.35M
77.54%-1.91M
64.16%-1.53M
8.29%-5.25M
71.57%-1.66M
-6.05%-24.33M
-60.20%-8.51M
29.40%-4.28M
5.63%-5.72M
-5.64%-5.82M
Income tax
0
-80K
Net income
57.34%-10.35M
77.33%-1.91M
64.16%-1.53M
8.29%-5.25M
71.57%-1.66M
-5.71%-24.25M
-58.69%-8.43M
29.40%-4.28M
5.63%-5.72M
-5.64%-5.82M
Net income continuous Operations
57.34%-10.35M
77.33%-1.91M
64.16%-1.53M
8.29%-5.25M
71.57%-1.66M
-5.71%-24.25M
-58.69%-8.43M
29.40%-4.28M
5.63%-5.72M
-5.64%-5.82M
Minority interest income
Net income attributable to the parent company
57.34%-10.35M
77.33%-1.91M
64.16%-1.53M
8.29%-5.25M
71.57%-1.66M
-5.71%-24.25M
-58.69%-8.43M
29.40%-4.28M
5.63%-5.72M
-5.64%-5.82M
Preferred stock dividends
Other preferred stock dividends
618K
0
618K
0
Net income attributable to common stockholders
54.79%-10.96M
77.33%-1.91M
49.71%-2.15M
8.29%-5.25M
71.57%-1.66M
-5.71%-24.25M
-58.69%-8.43M
29.40%-4.28M
5.63%-5.72M
-5.64%-5.82M
Basic earnings per share
59.84%-2
84.52%-0.26
52.94%-0.4
10.43%-1.03
75.37%-0.33
5.68%-4.98
-37.70%-1.68
38.85%-0.85
23.33%-1.15
10.67%-1.34
Diluted earnings per share
59.84%-2
84.52%-0.26
52.94%-0.4
10.43%-1.03
75.37%-0.33
5.68%-4.98
-37.70%-1.68
38.85%-0.85
23.33%-1.15
10.67%-1.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -65.48%6.96M-60.38%1.6M-64.00%1.58M-68.54%1.84M-67.03%1.95M-18.90%20.16M-31.41%4.04M-28.58%4.38M-5.20%5.84M-11.67%5.9M
Selling and administrative expenses -21.24%6.88M-3.73%1.6M-26.38%1.58M-25.57%1.84M-24.23%1.86M-15.85%8.73M-25.20%1.66M-24.55%2.14M-5.08%2.47M-9.44%2.46M
-General and administrative expense -21.24%6.88M-3.73%1.6M-26.38%1.58M-25.57%1.84M-24.23%1.86M-15.85%8.73M-25.20%1.66M-24.55%2.14M-5.08%2.47M-9.44%2.46M
Research and development costs -99.26%85K--0--0--0-97.53%85K-21.09%11.43M-35.17%2.38M-32.05%2.24M-5.28%3.37M-13.20%3.45M
Operating profit 65.48%-6.96M60.38%-1.6M64.00%-1.58M68.54%-1.84M67.03%-1.95M15.16%-20.16M31.41%-4.04M28.58%-4.38M5.20%-5.84M-5.66%-5.9M
Net non-operating interest income expense
Other net income (expense) 18.81%-3.39M93.03%-312K-57.55%45K-2,940.00%-3.41M271.79%290K-605.95%-4.17M-880.98%-4.48M34.18%106K21.21%120K6.85%78K
Gain on sale of security ---3.16M--0-------3.46M--294K--------------------
Special income (charges) 100.84%37K98.35%-73K--0--110K-----1,015.50%-4.43M---4.43M--0--0----
-Less:Impairment of capital assets --0------------------4.43M----------------
-Gain on sale of business ----------------------0----------------
-Gain on sale of property,plant,equipment --37K---73K--0--110K------0--0--0--0----
Other non- operating income (expenses) -199.62%-261K-443.18%-239K-57.55%45K-152.50%-63K-105.13%-4K-22.94%262K-149.44%-44K34.18%106K21.21%120K6.85%78K
Income before tax 57.48%-10.35M77.54%-1.91M64.16%-1.53M8.29%-5.25M71.57%-1.66M-6.05%-24.33M-60.20%-8.51M29.40%-4.28M5.63%-5.72M-5.64%-5.82M
Income tax 0-80K
Net income 57.34%-10.35M77.33%-1.91M64.16%-1.53M8.29%-5.25M71.57%-1.66M-5.71%-24.25M-58.69%-8.43M29.40%-4.28M5.63%-5.72M-5.64%-5.82M
Net income continuous Operations 57.34%-10.35M77.33%-1.91M64.16%-1.53M8.29%-5.25M71.57%-1.66M-5.71%-24.25M-58.69%-8.43M29.40%-4.28M5.63%-5.72M-5.64%-5.82M
Minority interest income
Net income attributable to the parent company 57.34%-10.35M77.33%-1.91M64.16%-1.53M8.29%-5.25M71.57%-1.66M-5.71%-24.25M-58.69%-8.43M29.40%-4.28M5.63%-5.72M-5.64%-5.82M
Preferred stock dividends
Other preferred stock dividends 618K0618K0
Net income attributable to common stockholders 54.79%-10.96M77.33%-1.91M49.71%-2.15M8.29%-5.25M71.57%-1.66M-5.71%-24.25M-58.69%-8.43M29.40%-4.28M5.63%-5.72M-5.64%-5.82M
Basic earnings per share 59.84%-284.52%-0.2652.94%-0.410.43%-1.0375.37%-0.335.68%-4.98-37.70%-1.6838.85%-0.8523.33%-1.1510.67%-1.34
Diluted earnings per share 59.84%-284.52%-0.2652.94%-0.410.43%-1.0375.37%-0.335.68%-4.98-37.70%-1.6838.85%-0.8523.33%-1.1510.67%-1.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -